23 May 2013
Keywords: 1st-qtr, results, france, transgene, french, biopharmaceutical, firm
Article | 12 May 2003
French biopharmaceutical firm Transgene has reported a net loss of 4.8 million euros ($5.4 million) for the first quarter of 2003, the same ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 May 2003
© 2013 thepharmaletter.com